Research replication

New England Journal of Medicine

Volumn 355, Issue 21, 2006, Pages 2252-2253

  Drazen, Jeffrey M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; TRANEXAMIC ACID;

BLEEDING; DISEASE CONTROL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART SURGERY; HUMAN; MEDICAL RESEARCH; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL;

ANTIFIBRINOLYTIC AGENTS; APROTININ; CARDIAC SURGICAL PROCEDURES; DATA INTERPRETATION, STATISTICAL; DRUG APPROVAL; HUMANS; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33751236801     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe068271     Document Type: Editorial

References (4)

1. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.
2. Hiatt WR. Observational studies of drug safety - aprotinin and the absence of transparency. N Engl J Med 2006;355:2171-3.
3. Mangano DT. Judging the safety of aprotinin. N Engl J Med 2006;355:2261-2.
4. Rieves RD, Weiss KD. Judging the safety of aprotinin. N Engl J Med 2006;355:2262.